Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 09/22/09 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/09/09 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
24 | |
| 09/09/09 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
54 | |
| 09/04/09 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
14 | |
| 09/04/09 | 8-K/A | Current report filing |
|
4 | |
| 09/01/09 | 8-K | Current report filing |
|
4 | |
| 08/21/09 | UPLOAD | SEC-generated letter |
|
6 | |
| 08/20/09 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/11/09 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
23 | |
| 07/13/09 | 8-K | Current report filing |
|
4 |
